Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRP78/BiP is a master endoplasmic reticulum chaperone protein of the HSP70 family that guides proper folding and assembly of nascent proteins, prevents misfolding and aggregation, and targets misfolded proteins for proteasome degradation. It is central to the unfolded protein response (UPR), acting as a direct repressor of ER stress sensors, and thereby controls adaptation to cellular stress. Under disease conditions, including cancer, neurodegeneration, infection, and inflammation, GRP78 is often upregulated and can translocate to the cell surface, modulating immune signaling and serving as a viral entry point. It is increasingly recognized as a therapeutic target for diseases involving protein misfolding and ER stress
Inhibition or induction of GRP78 alters protein folding, UPR signaling, and cell fate (death or survival) Modulation of cell surface localization impacts tumor cell survival and viral entry Chemical induction of GRP78 can protect cells from ER stress-mediated death
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 78-kDa glucose-regulated protein (Binding immunoglobulin protein) (GRP78 or BiP).